Celldex is developing targeted therapeutics to address devastating diseases for which available treatments are inadequate. There pipeline is built from a proprietary portfolio of antibodies and immunomodulators used alone and in strategic combinations to create novel, disease-specific therapies that induce, enhance or suppress the body's immune response
Celldex is developing targeted therapeutics to address devastating diseases for which available treatments are inadequate. There pipeline is built from a proprietary portfolio of antibodies and immunomodulators used alone and in strategic combinations to create novel, disease-specific therapies that induce, enhance or suppress the body's immune response
Recent Articles
- Join the Transformation at A4M's Upcoming Longevity Events
- Uzbekistan's HUMO Token: A Revolution in Asset-Backed Crypto
- BlockQuarry Leads the Way in U.S. Bitcoin Mining Innovation
- Chino Commercial Bank Earns Elite Performance Status in Finance
- Stifel and U.S. Ski & Snowboard's Visionary Partnership Expansion
- Middlefield Canadian Income PCC Reports Latest Net Asset Values
- HKUST Foundation Gala Dinner: A New Era of Innovation Begins
- CoinShares Initiates Strategic Share Buyback from Shareholder
- Reliance Global Group Prepares for First Quarter Earnings Call
- Urgent Call for Change at Servotronics: Safeguarding Future Value
- Athira Pharma Unveils Promising ATH-1105 Data at ALS Summit
- Tri-anim and Telesair Form Alliance for Innovative Oxygen Therapy
- Leadership Change at Segmed: New CEO and Board Additions
- CorroHealth Achieves Recognition as Top Workplace in Healthcare
- Webull Corporation's Financial Results Announcement Details
- Transformations in the Forklift Market: Growth Trends and Innovations
- Chronicle Heritage Welcomes Jonielle Dedman as CEO
- Exploring the Enormous Growth Potential of Sustainable Packaging
- Nayya Partners with Oracle for Enhanced Employee Benefits
- Integra Therapeutics Unveils Breakthrough Data on Gene Therapy Innovations
- Unleashing the Power of Customer Feedback in B2B SaaS
- AstraZeneca's Innovative AZD1390 Launches in Global Trial
- Ubiquity Enhances Credit Facility to Accelerate Growth Initiatives
- Golden West Food Group Introduces Innovative Jack Daniel's Sausages
- Pallini Limoncello Marks 150 Years with Campaign of Flavor
- Discover Viva Chefs: Your Personal Culinary Solution
- FCP Elevates Leadership with Key Promotions and Strategy
- AviLease Expands Fleet with First Direct Boeing Order
- GridGain Elevates Real-Time AI with New Platform Features
- Understanding How SkillCycle Transforms Future Work Dynamics
- OSF Digital Welcomes Simon Mulcahy as Executive Advisor for Growth
- Innovative Smart Robots Market Projected to Hit $135.83 Billion
- SkinCeuticals and LaserAway Partner for Skin Health Revolution
- Revolutionizing Patient Care: Lifestyle Medicine Tools Integrated
- Arkos Health Welcomes Eric Tanner as New CEO for Growth
- Exciting Prizes Await in Dandy Celery's New Contest
- Boat Sails Market Growth to Reach USD 1.10 Billion Soon
- Barcode Software Market Growth Predictions Through 2031
- Unlocking America's $150 Trillion Resource for Energy Relief
- Maximize Your Crypto Gains with BexBack's Innovative Features
- BTCC Exchange Strengthens Trust with New Proof of Reserves Report
- Exploring Sustainable Cloud Mining for Digital Assets Growth
- Insight into Rathbones Group's Recent Market Activities
- Texaf Announces Increased Dividend of 1.23 EUR per Share
- CSX Corporation's CCO to Shine at Upcoming Transportation Conference
- Surging Demand for AI Expertise Sparks Freelance Revolution
- Understanding the Public Opening Position for Assura Plc
- Insight into Life Science REIT's Significant Shareholder Activities
- Insights on Rathbones Group's Role in LondonMetric Property Plc
- Understanding Shareholder Disclosures from Primary Health Properties